Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
288 hedge funds and large institutions have $3.07B invested in Amedisys in 2022 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 106 increasing their positions, 109 reducing their positions, and 71 closing their positions.
0.01% more ownership
Funds ownership: 92.87% → 92.87% (+0.01%)
3% less repeat investments, than reductions
Existing positions increased: 106 | Existing positions reduced: 109
12% less funds holding
Funds holding: 328 → 288 (-40)
41% less capital invested
Capital invested by funds: $5.19B → $3.07B (-$2.11B)
46% less first-time investments, than exits
New positions opened: 38 | Existing positions closed: 71
48% less call options, than puts
Call options by funds: $18.4M | Put options by funds: $35.3M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$71.9M |
| 2 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$45.7M |
| 3 |
JP Morgan Chase
New York
|
+$38.6M |
| 4 |
DM
Deerfield Management
New York
|
+$25.4M |
| 5 |
Morgan Stanley
New York
|
+$19.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair Investment Management
Chicago,
Illinois
|
-$124M |
| 2 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$48.3M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$43.7M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$41.2M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$34.3M |
AMED Hedge Fund Activity: Q2 2022 in Review
288 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q2 2022, worth a combined $3.07B — down 41% from $5.19B a quarter earlier.
Sellers outnumbered buyers: 71 funds closed out of AMED and 38 opened new positions — a net loss of 33 holders — while 109 trimmed existing stakes and 106 added.
The largest buyer was Wellington Management Group, adding an estimated $71.9M. The largest seller was William Blair Investment Management, exiting entirely with an estimated $124M sold.
- 288 institutional investors held Amedisys (AMED) as of Q2 2022, down from 328 in Q1 2022.
- Funds reported $3.07B of Amedisys stock for Q2 2022, down 41% quarter-over-quarter.
- 38 funds opened new Amedisys positions in Q2 2022 and 71 closed out, a net change of -33 holders.
- The largest Amedisys buyer in Q2 2022 was Wellington Management Group, an estimated $71.9M added.
- The largest Amedisys seller in Q2 2022 was William Blair Investment Management, an estimated $124M sold.
Based on aggregated 13F filings for Q2 2022.